(Q41103096)

26 September 2017

1 reference

title

Cytotoxic T lymphocyte responses to Epstein-Barr virus (English)

1 reference

26 September 2017

0 references

0 references

Rickinson AB

1

1 reference

PubMed ID

8794020

26 September 2017

Lee SP

series ordinal

2

1 reference

PubMed ID

8794020

26 September 2017

Steven NM

series ordinal

3

1 reference

26 September 2017

1 August 1996

1 reference

Current Opinion in Immunology

26 September 2017

1 reference

26 September 2017

8

1 reference

26 September 2017

492-497

1 reference

26 September 2017

4

1 reference

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

Major histocompatibility complex class I-restricted cytotoxic T lymphocyte responses to Epstein-Barr virus in children

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

Sequence variation in the Epstein-Barr virus latent membrane protein 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

Degradation of subunits of the Sec61p complex, an integral component of the ER membrane, by the ubiquitin-proteasome pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3)

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

Characterization of two Epstein-Barr virus epitopes restricted by HLA-B7.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

Epstein-Barr virus isolates with the major HLA B35.01-restricted cytotoxic T lymphocyte epitope are prevalent in a highly B35.01-positive African population

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

Large clonal expansions of CD8+ T cells in acute infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

Recruitment during infectious mononucleosis of CD3+CD4+CD8+ virus-specific cytotoxic T cells which recognise Epstein-Barr virus lytic antigen BHRF1.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

Unusually high frequency of Epstein-Barr virus genetic variants in Papua New Guinea that can escape cytotoxic T-cell recognition: implications for virus evolution.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

A recombinant adenovirus expressing an Epstein-Barr virus (EBV) target antigen can selectively reactivate rare components of EBV cytotoxic T-lymphocyte memory in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980036-7

7 January 2021

10.1016/S0952-7915(96)80036-7

Identifiers

DOI

1 reference

26 September 2017

1 reference

PubMed ID

8794020